Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
X. Ruan & A. O. Mueck. (2023) The WHO claims estrogens are ‘carcinogenic’: is this true?. Climacteric 26:3, pages 263-270.
Read now
Read now
X. Li, X. Ruan, M. Gu & A. O. Mueck. (2019) PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol. Climacteric 22:5, pages 483-488.
Read now
Read now
Nicole C. Clark, Anne M. Friel, Cindy A. Pru, Ling Zhang, Toshi Shioda, Bo R. Rueda, John J. Peluso & James K. Pru. (2016) Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors. Cancer Biology & Therapy 17:3, pages 262-271.
Read now
Read now
Ying Zhang, Xiangyan Ruan, Marina Willibald, Harald Seeger, Tanja Fehm, Hans Neubauer & Alfred O. Mueck. (2016) May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?. Gynecological Endocrinology 32:1, pages 58-60.
Read now
Read now
H. Neubauer, Q. Ma, J. Zhou, Q. Yu, X. Ruan, H. Seeger, T. Fehm & A. O. Mueck. (2013) Possible role of PGRMC1 in breast cancer development. Climacteric 16:5, pages 509-513.
Read now
Read now
Helen Schneck, Xiangyan Ruan, Harald Seeger, Michael A. Cahill, Tanja Fehm, Alfred O. Mueck & Hans Neubauer. (2013) Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological Endocrinology 29:2, pages 160-162.
Read now
Read now
Xiangyan Ruan, Helen Schneck, Silke Schultz, Tanja Fehm, Michael A. Cahill, Harald Seeger, Rong Chen, Qi Yu, Alfred O. Mueck & Hans Neubauer. (2012) Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells. Gynecological Endocrinology 28:11, pages 863-866.
Read now
Read now
X. Ruan, H. Neubauer, Y. Yang, H. Schneck, S. Schultz, T. Fehm, M. A. Cahill, H. Seeger & A. O. Mueck. (2012) Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 15:5, pages 467-472.
Read now
Read now
Articles from other publishers (40)
Nodoka Sugiyama, Osamu Uehara, Yutaka Kawano, Durga Paudel, Tetsuro Morikawa, Norihiro Nakamoto, Satsuki Kato, Tetsuji Takayama, Toshiyuki Nagasawa, Hiroko Miura, Yoshihiro Abiko & Yasushi Furuichi. (2023) Ingenuity pathway analysis of gingival epithelial cells stimulated with estradiol and progesterone. Journal of Oral Biosciences.
Crossref
Crossref
Revathi Gnanasekaran, Justin Aickareth, Majd Hawwar, Nickolas Sanchez, Jacob Croft & Jun Zhang. (2023) CmPn/CmP Signaling Networks in the Maintenance of the Blood Vessel Barrier. Journal of Personalized Medicine 13:5, pages 751.
Crossref
Crossref
James K Pru. (2022) Pleiotropic Actions of PGRMC Proteins in Cancer. Endocrinology 163:7.
Crossref
Crossref
Xin Xu, Xiangyan Ruan, Rui Ju, Zhikun Wang, Yu Yang, Jiaojiao Cheng, Muqing Gu & Alfred O. Mueck. (2022) Progesterone Receptor Membrane Component-1 May Promote Survival of Human Brain Microvascular Endothelial Cells in Alzheimer’s Disease. American Journal of Alzheimer's Disease & Other Dementias® 37, pages 153331752211097.
Crossref
Crossref
Zhi Xia, Jian Xiao & Qiong Chen. (2021) Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?. Biomolecules 11:11, pages 1686.
Crossref
Crossref
Mirco Masi, Marco Racchi, Cristina Travelli, Emanuela Corsini & Erica Buoso. (2021) Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers. Cells 10:11, pages 2999.
Crossref
Crossref
Evangelia Sereti, Chrisiida Tsimplouli, Elisavet Kalaitsidou, Nikos Sakellaridis & Konstantinos Dimas. (2021) Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel. Biomedicines 9:1, pages 38.
Crossref
Crossref
Bashar M. Thejer, Partho P. Adhikary, Sarah L. Teakel, Johnny Fang, Paul A. Weston, Saliya Gurusinghe, Ayad G. Anwer, Martin Gosnell, Jalal A. Jazayeri, Marina Ludescher, Lesley-Ann Gray, Michael Pawlak, Robyn H. Wallace, Sameer D. Pant, Marie Wong, Tamas Fischer, Elizabeth J. New, Tanja N. Fehm, Hans Neubauer, Ewa M. Goldys, Jane C. Quinn, Leslie A. Weston & Michael A. Cahill. (2020) PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease. BMC Molecular and Cell Biology 21:1.
Crossref
Crossref
Carlos Cantonero, Ginés M. Salido, Juan A. Rosado & Pedro C. Redondo. (2020) PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells. International Journal of Molecular Sciences 21:20, pages 7641.
Crossref
Crossref
Diego A. Pedroza, Ramadevi Subramani & Rajkumar Lakshmanaswamy. (2020) Classical and Non-Classical Progesterone Signaling in Breast Cancers. Cancers 12:9, pages 2440.
Crossref
Crossref
Britton Trabert, Mark E Sherman, Nagarajan Kannan & Frank Z Stanczyk. (2020) Progesterone and Breast Cancer. Endocrine Reviews 41:2, pages 320-344.
Crossref
Crossref
Xiangyan Ruan, Guiju Cai, Yun Wei, Muqing Gu, Ying Zhang, Yue Zhao & Alfred O. Mueck. (2020) Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. Menopause 27:2, pages 183-193.
Crossref
Crossref
Domenica Roberto, Shamini Selvarajah, Paul C. Park, David Berman & Vasundara Venkateswaran. (2019) Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci. The Prostate 79:15, pages 1777-1788.
Crossref
Crossref
Xiangyan Ruan, Muqing Gu, Guiju Cai, Yue Zhao, Lijuan Wang, Xue Li & Alfred O. Mueck. (2019) Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study. Maturitas 123, pages 1-8.
Crossref
Crossref
Hilary E. Nicholson, Walid F. Alsharif, Anthony B. Comeau, Christophe Mesangeau, Sebastiano Intagliata, Marco Mottinelli, Christopher R. McCurdy & Wayne D. Bowen. (2019)
Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[
d
]oxazol-2(3
H
)-one (SN79) Derivatives
. Journal of Pharmacology and Experimental Therapeutics 368:2, pages 272-281.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Crossref
Aladdin Riad, Chenbo Zeng, Chi-Chang Weng, Harrison Winters, Kuiying Xu, Mehran Makvandi, Tyler Metz, Sean Carlin & Robert H. Mach. (2018) Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. Scientific Reports 8:1.
Crossref
Crossref
Laura Terzaghi, Alberto Maria Luciano, Priscila C Dall’Acqua, Silvia C Modina, John J Peluso & Valentina Lodde. (2018) PGRMC1 localization and putative function in the nucleolus of bovine granulosa cells and oocytes. Reproduction 155:3, pages 273-282.
Crossref
Crossref
Yue Zhao, Xiangyan Ruan, Husheng Wang, Xue Li, Muqing Gu, Lijuan Wang, Yanglu Li, Harald Seeger & Alfred O. Mueck. (2017) The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model. Maturitas 102, pages 26-33.
Crossref
Crossref
Michael A. Cahill & Amy E. Medlock. (2017) Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands. The Journal of Steroid Biochemistry and Molecular Biology 171, pages 11-33.
Crossref
Crossref
Xiangyan Ruan, Ying Zhang, Alfred O. Mueck, Marina WillibaldHarald Seeger, Tanja FehmSara Brucker & Hans Neubauer. (2017) Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer. Menopause 24:2, pages 203-209.
Crossref
Crossref
Michael A. Cahill, Jalal A. Jazayeri, Susan M. Catalano, Shinya Toyokuni, Zaklina Kovacevic & Des R. Richardson. (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:2, pages 339-349.
Crossref
Crossref
H. Nicholson, C. Mesangeau, C. R. McCurdy & W. D. Bowen. (2015) Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma. Journal of Pharmacology and Experimental Therapeutics 356:2, pages 434-445.
Crossref
Crossref
Eugenie Wong Soon May, Szu-Ting Lin, Chi-Chen Lin, Jo-Fan Chang, Eric Hung, Yi-Wen Lo, Li-Hsun Lin, Ren-Yu Hu, Chi-Lun Feng, Dai-Ying Lin, Shine-Bei Wu, Wen-Chi Lee, Kevin W. Lyu, Hsiu-Chuan Chou & Hong-Lin Chan. (2014) Identification of up- and down-regulated proteins in doxorubicin-resistant uterine cancer cells: Reticulocalbin-1 plays a key role in the development of doxorubicin-associated resistance. Pharmacological Research 90, pages 1-17.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2014) Risiko von Brustkrebs unter „hormone replacement therapy“Risk of breast cancer with hormone replacement therapy. Gynäkologische Endokrinologie 12:3, pages 149-155.
Crossref
Crossref
A.O. Mueck, X. Ruan, H. Seeger, T. Fehm & H. Neubauer. (2014) Genomic and non-genomic actions of progestogens in the breast. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 62-67.
Crossref
Crossref
Ji-Min Li, Hsiu-Chuan Chou, Ssu-Han Wang, Chieh-Lin Wu, Yi-Wen Chen, Szu-Ting Lin, Yu-Hua Chen & Hong-Lin Chan. (2013) Hyaluronic acid-dependent protection against UVB-damaged human corneal cells. Environmental and Molecular Mutagenesis 54:6, pages 429-449.
Crossref
Crossref
Hans Neubauer, Xiangyan Ruan, Helen Schneck, Harald Seeger, Michael A. Cahill, Yayun Liang, Benfor Mafuvadze, Salman M. Hyder, Tanja Fehm & Alfred O. Mueck. (2013) Overexpression of progesterone receptor membrane component 1. Menopause 20:5, pages 504-510.
Crossref
Crossref
Szu-Ting Lin, Yi-Wen Lo, Shing-Jyh Chang, Wen-Ching Wang, Margaret Dah-Tsyr Chang, Ping-Chiang Lyu, Yi-Wen Chen, Hsiu-Chuan Chou & Hong-Lin Chan. (2013) Redox-proteomic analysis of doxorubicin resistance-induced altered thiol activity in uterine carcinoma. Journal of Pharmaceutical and Biomedical Analysis 78-79, pages 1-8.
Crossref
Crossref
Alberto Maria Luciano, Federica Franciosi, Valentina Lodde, Irene Tessaro, Davide Corbani, Silvia Clotilde Modina & John J. Peluso. (2013) Oocytes Isolated from Dairy Cows with Reduced Ovarian Reserve Have a High Frequency of Aneuploidy and Alterations in the Localization of Progesterone Receptor Membrane Component 1 and Aurora Kinase B1. Biology of Reproduction 88:3.
Crossref
Crossref
Szu-Ting Lin, Hsiu-Chuan Chou, Shing-Jyh Chang, Yi-Wen Chen, Ping-Chiang Lyu, Wen-Ching Wang, Margaret Dah-Tsyr Chang & Hong-Lin Chan. (2012) Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. Journal of Proteomics 75:18, pages 5822-5847.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2011) Medikamentöse Therapiemöglichkeiten in der MenopauseMedicinal therapy options in the menopause. Gynäkologische Endokrinologie 9:3, pages 151-157.
Crossref
Crossref
Frank Z. Stanczyk. (2011) Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1?. Menopause 18:8, pages 833-834.
Crossref
Crossref
Hans Neubauer, Yang Yang, Harald Seeger, Tanja Fehm, Michael A. Cahill, Xiaowen Tong, Xiangyan Ruan & Alfred O. Mueck. (2011) The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells. Menopause 18:8, pages 845-850.
Crossref
Crossref
Jinbin Xu, Chenbo Zeng, Wenhua Chu, Fenghui Pan, Justin M. Rothfuss, Fanjie Zhang, Zhude Tu, Dong Zhou, Dexing Zeng, Suwanna Vangveravong, Fabian Johnston, Dirk Spitzer, Katherine C. Chang, Richard S. Hotchkiss, William G. Hawkins, Kenneth T. Wheeler & Robert H. Mach. (2011) Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nature Communications 2:1.
Crossref
Crossref
Yanyun XieAnthony BruceLizhi HeFengxiang WeiLijian TaoDamu Tang. (2011) CYB5D2 enhances HeLa cells survival of etoposide-induced cytotoxicity. Biochemistry and Cell Biology 89:3, pages 341-350.
Crossref
Crossref
Alfred O. Mueck & Xiangyan Ruan. (2011) Benefits and risks during HRT: main safety issue breast cancer. Hormone Molecular Biology and Clinical Investigation 5:2.
Crossref
Crossref
Hans Neubauer, Rong Chen, Helen Schneck, Thomas Knorrp, Markus F. Templin, Tanja Fehm, Michael A. Cahill, Harald Seeger, Qi Yu & Alfred O. Mueck. (2011) New insight on a possible mechanism of progestogens in terms of breast cancer risk. Hormone Molecular Biology and Clinical Investigation 6:1.
Crossref
Crossref
Xiao-Dong Fu, Eleonora Russo, Sara Zullino, Andrea R. Genazzani & Tommaso Simoncini. (2010) Sex steroids and breast cancer metastasis. Hormone Molecular Biology and Clinical Investigation 3:2.
Crossref
Crossref
Alfred O. Mueck, Harald Seeger & Samuel Shapiro. (2010) Risk of breast cancer during hormone replacement therapy: mechanisms. Hormone Molecular Biology and Clinical Investigation 3:1.
Crossref
Crossref